CIK 0001576280 · Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454139254
- Phone
- 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,739,100
- in 9 filings, $213K under 10b5-1 plans
Net −$9,739,100. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Kalia Kumud Chief Information Officer | Option exercise · Restricted Stock Units | −1,607 | 1,607 | ||
| 2026-07-01 | Kalia Kumud Chief Information Officer | Option exercise · Restricted Stock Units | −1,084 | 1,084 | ||
| 2026-07-01 | Kalia Kumud Chief Information Officer | Option exercise · Restricted Stock Units | −1,994 | 9,973 | ||
| 2026-07-01 | Kalia Kumud Chief Information Officer | Option exercise · Restricted Stock Units | −1,361 | 9,522 | ||
| 2026-07-01 | Freeman Chris Chief Commercial Officer | Option exercise | +1,928 | 63,029 | ||
| 2026-07-01 | Freeman Chris Chief Commercial Officer | Option exercise | +1,667 | 64,696 | ||
| 2026-07-01 | Freeman Chris Chief Commercial Officer | Option exercise | +2,526 | 67,222 | ||
| 2026-07-01 | Freeman Chris Chief Commercial Officer | Option exercise | +1,293 | 68,515 | ||
| 2026-07-01 | Freeman Chris Chief Commercial Officer | Shares withheld for taxes | −3,141 | $170.77 | $536K | 65,374 |
| 2026-07-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,928 | 1,929 | ||
| 2026-07-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,667 | 1,668 | ||
| 2026-07-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −2,526 | 12,632 | ||
| 2026-07-01 | Freeman Chris Chief Commercial Officer | Option exercise · Restricted Stock Units | −1,293 | 9,046 | ||
| 2026-07-01 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise | +23,997 | 1,906,722 | ||
| 2026-07-01 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise | +9,715 | 1,916,437 | ||
| 2026-07-01 | Talasaz AmirAli Co-Chief Executive Officer | Shares withheld for taxes | −17,086 | $170.77 | $2.9M | 1,899,351 |
| 2026-07-01 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −23,997 | 47,995 | ||
| 2026-07-01 | Talasaz AmirAli Co-Chief Executive Officer | Option exercise · Restricted Stock Units | −9,715 | 58,296 | ||
| 2026-07-01 | Eltoukhy Helmy Co-Chief Executive Officer | Option exercise | +23,997 | 2,038,305 | ||
| 2026-07-01 | Eltoukhy Helmy Co-Chief Executive Officer | Option exercise | +9,715 | 2,048,020 |
Page 9 of 22 · 421 trades